— Know what they know.
Not Investment Advice

BVS NASDAQ

Bioventus Inc.
1W: -4.9% 1M: -8.6% 3M: +11.5% YTD: +82.1% 1Y: +95.7% 3Y: +334.8% 5Y: -10.4%
$13.13
-0.32 (-2.38%)
 
Weekly Expected Move ±4.9%
$12 $12 $13 $14 $14
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 50 · $889.5M mcap · 47M float · 1.45% daily turnover · Short 76% of daily vol

📊 Key Metrics

TTM
$582M
Revenue
+3.1% YoY
$54M
Net Income
+34570.9% YoY
$94M
Free Cash Flow
+176.5% YoY
69.0%
Gross Margin
12.5%
Op. Margin
21.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE28.0%
ROA7.9%
ROIC21.3%

Valuation

P/E16.3
P/B3.9
EV/EBITDA10.0

Leverage

Debt/Equity1.16
Current Ratio1.69
Interest Cov.2.9x

Quality Scores

Piotroski F7/9
Altman Z1.77
Beneish M-2.71

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms